Keywords: تاموکسیفن; Steroid hormone receptors; Estrogen; Androgen; Hormone therapy; Tamoxifen; Melanoma; ER; estrogen receptor; AR; androgen receptor;
مقالات ISI تاموکسیفن (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: تاموکسیفن; Raloxifene; Tamoxifen; Ovariectomy; Vascular reactivity; Cytokines;
Keywords: تاموکسیفن; CI; cortex-injured group; PI; penetrating injury; PLM; pendulum-like movement; hippocampus; traumatic brain injury; locomotion; tamoxifen; neuroprotection;
Keywords: تاموکسیفن; Cytostatic drugs; Transformation products; Chlorine; Orbitrap; Reactivity; Tamoxifen;
Keywords: تاموکسیفن; Toremifene; Tamoxifen; Metabolite kinetics; Bioactivation; CYP2D6; CYP3A4; CYP2C9; Pharmacogenomics; PolymorphismsTOR, toremifene; TAM, tamoxifen; SERM, selective estrogen receptor modulator; SSRI, selective serotonin reuptake inhibitor; 4OH, 4-hydroxy; N
Keywords: تاموکسیفن; Advanced glycation end products; Breast cancer; Estrogen receptor; IGF1-receptor; GPER; Tamoxifen
Keywords: تاموکسیفن; Angiogenesis; Selective estrogen receptor modulator; Tamoxifen; Cholesterol trafficking
Keywords: تاموکسیفن; Breast neoplasms; Humans; Neoplasm staging; Prognosis; Oestrogen receptor; Progesterone receptor; Tissue microarray analysis; Radiotherapy; Hormonal antineoplastic agents; Tamoxifen;
Keywords: تاموکسیفن; Soy; Tamoxifen; Seizure; Dark neuron; Hippocampus
Keywords: تاموکسیفن; SL; sphingolipid; S1P; sphingosine 1-phosphate; GCS; glucosylceramide synthase; GC; glucosylceramide; AC; ceramidase; SphK; sphingosine kinase; PPMP; D-threo-1-phenyl-2-hexadecanoylamino-3-morpholino-1-propanol; PDMP; D-threo-1-phenyl-2-decanoylamino-3-mo
Keywords: تاموکسیفن; Metabolic syndrome; Sperm quality; Testis; Epididymis; Tamoxifen;
Keywords: تاموکسیفن; Systems biology; Endocrine resistance; Breast cancer; Computational biology; Unfolded protein response; Tamoxifen; Antiestrogens; Autophagy
Keywords: تاموکسیفن; Breast cancer; Tamoxifen; Pluripotency; Endocrine resistance; Transcriptomic analysis; Cell lines; Patient data
Keywords: تاموکسیفن; Omega-3 free fatty acids; Tamoxifen; Breast cancer; Cell apoptosis; Fish oil;
Keywords: تاموکسیفن; Citrate synthase; Succinate dehydrogenase; Malate dehydrogenase; Amphetamine; Tamoxifen
Keywords: تاموکسیفن; Antibacterial; Tamoxifen; Citrate salt; Organometallic compounds; Ion efflux; Transmission electron microscopy
Keywords: تاموکسیفن; Ductal carcinoma in situ; DCIS; Tamoxifen;
Keywords: تاموکسیفن; Breast neoplasms; Tamoxifen; Cohort studies;
Keywords: تاموکسیفن; aHR; adjusted hazard ratio; aOR; adjusted odds ratios; CAM; complementary and alternative medicine; CHP; Chinese herbal products; CI; confidence intervals; DCMP; Department of Chinese Medicine and Pharmacy; ER; estrogen receptor; HR; hazard ratio; ICD-9-C
Keywords: تاموکسیفن; Tamoxifen; Sex determination; Sex reversal; Endocrine-disrupting chemicals
Keywords: تاموکسیفن; Breast cancer; Aromatase inhibitor; Tamoxifen; Arthralgia; IGF-I; Oestrogens;
Keywords: تاموکسیفن; Tamoxifen; Senescence; ROS; p53; Protein kinase CK2
Keywords: تاموکسیفن; Breast implant capsules; Oestrogen receptors; Capsular contracture; Anti-oestrogens; Tamoxifen
Keywords: تاموکسیفن; Tamoxifen; Hyperthyroidism; Heart damage; Ischemia/reperfusion; Mitochondria; Permeability transition;
Keywords: تاموکسیفن; Endometrial cancer; Breast cancer; Tamoxifen; Prognosis of endometrial cancer
Keywords: تاموکسیفن; Breast cancer; Endocrine therapy; Iowa Gambling Task; Game of Dice Task; Tamoxifen;
Keywords: تاموکسیفن; SERMs; Ospemifene; Tamoxifen; Anti-breast cancer agents; Docking studies
Keywords: تاموکسیفن; Tamoxifen; Phospholipid; Tamoxifen-phospholipid complex; Solubility; Oral bioavailability;
Keywords: تاموکسیفن; Tamoxifen; Cardiac hypertrophy; Isoproterenol (ISO); Partial abdominal aortic constriction (PAAC)
Keywords: تاموکسیفن; Tamoxifen; Endoxifen; Mitochondria; Hepatotoxicity;
Keywords: تاموکسیفن; Adjuvant therapy; Breast cancer hormonal therapy, CYP2D6, Selective estrogen receptor modulators; Tamoxifen;
Keywords: تاموکسیفن; NAFLD; Non-alcoholic fatty liver disease; dG-TAM; (E)-α-(deoxyguanosin-N2-yl)-tamoxifen; dG-DesMeTAM; (E)-α-(deoxyguanosin-N2-yl)-N-desmethyltamoxifen; ALT; alanine transaminase; AST; aspartate transaminase; LDH; lactate dehydrogenase; α-SMA; α-smooth
Keywords: تاموکسیفن; Anabolic-androgenic steroids; androgens; hypogonadotropic hypogonadism; gynecomastia; testicular atrophy; erectile dysfunction; clomiphene citrate; tamoxifen; human chorionic gonadotropin
Keywords: تاموکسیفن; Adherence; Aromatase inhibitors; Tamoxifen; Toxicity; Trastuzumab;
Keywords: تاموکسیفن; Ciprofloxacin; Tamoxifen; Cyclophosphamide; Wastewater; Hormesis; Bioassays;
Keywords: تاموکسیفن; Tamoxifen; Mania; Treatment; Bipolar disorder; Schizoaffective disorder; Medroxyprogesterone acetate;
Keywords: تاموکسیفن; Tamoxifen; Oestrogen; Membrane-associated molecules; Gene expression profiling;
Keywords: تاموکسیفن; Fluid percussion injury; Tamoxifen; Extracellular signal–regulated kinases (ERK1/2); Cell apoptosis; Infarction volume; Maximal angle
Keywords: تاموکسیفن; IVF; breast cancer; controlled ovarian hyperstimulation; tamoxifen; fertility preservation;
Keywords: تاموکسیفن; Tamoxifen; Nanostructured lipid carriers; Intestinal lymphatic system; Murine model; Hepatotoxicity;
Keywords: تاموکسیفن; apoptosis; Cre recombinase; inflammation; necrosis; tamoxifen;
Keywords: تاموکسیفن; ABEI; N-(4-aminobutyl)-N-ethylisoluminol; Ab; Antibody; ADM; Adriamycin; AFP; Alpha fetoprotein; Ag; Antigen; ALP; Alkaline phosphatase; ATP; Adenosine triphosphate; bbc-DL-DNA; bio-bar-code dendrimer-like DNA; BPE; Biophoton emission; CA; Carcinoma antig
Keywords: تاموکسیفن; Amplified spontaneous emission; Fluorescent drugs; Dye; Tamoxifen; Biophotonics;
Keywords: تاموکسیفن; U.S.; Anxiety; Behavioral decision-making; Breast cancer; Tamoxifen;
Keywords: تاموکسیفن; Lipid nanoparticles; Tamoxifen; Absorbance; Ostwald ripening; Mammary adenocarcinoma cell line; Drug delivery; Nanostructured lipid carrier (NLC);
Keywords: تاموکسیفن; Intermediate risk breast cancer; Apoptosis; Proliferation; Tamoxifen; Survival;
Keywords: تاموکسیفن; Decision aids; Tamoxifen; Raloxifene; Breast cancer prevention; Tailoring;
Keywords: تاموکسیفن; Drug-targeting; Prodigiosenes; Estrone; Tamoxifen; Porphyrin; Natural product; Anticancer;
Keywords: تاموکسیفن; Estrogen; Tamoxifen; Palatable foods; Chocolate; Lipid profile; Weight gain;
Keywords: تاموکسیفن; SERM; selective estrogen receptor modulator; BRCAT; breast cancer risk assessment tool; IBIS; International Breast Cancer Intervention Study Model; NSAID; non-steroidal anti-inflammatory; DCIS; ductal carcinoma in situ; OVX; ovariectomy; Tamoxifen; Postpa